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Abstract Sialic acids are essential components of cell-surface 
receptors utilized by influenza viruses. To evaluate the recogni- 
tion of asialic sugar parts of the receptor, three representative 
strains of human influenza A and B viruses were tested for their 
binding of a panel of sialyloligosaccharides. The highest affinity 
binding carbohydrate determinants recognized by the viruses in 
a context of different core structures were Neu5Aca2-3Gal for 
the type B virus, Neu5Aca2-6Gal for the H3 subtype virus, and 
Neu5Aca2-6Gal~l-4GlcNAc for the H1 subtype virus. Penulti- 
mate to these determinants parts of sialyloligosaccharides studied 
either contributed less significantly to the binding affinity, or 
interfered with the binding. 
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1. Introduction 
Sialic acids are minimum essential determinants of cell sur- 
face receptors of influenza viruses recognized by the viral at- 
tachment protein hemagglutinin (HA) (for review, see [1,2]). 
Sialyloligosaccharide moieties of cell-surface glycoproteins and 
glycolipids exhibit significant structural diversity, and numer- 
ous studies indicate that the ability of sialic acid to serve as a 
receptor determinant of influenza virus may be influenced by 
the carbohydrate structure of sialylglycoprotein [1,3-5], gangli- 
oside [6-9], or sialyloligosaccharide [10-12] to which it is at- 
tached. Particulary well documented is the ability of the viruses 
to differentiate between the Neu5Ac~2-3Gal- and Neu5Ac~2- 
6Gal-terminated sequences, while contribution ofmore distant 
carbohydrate parts of the receptor is poorly defined. In our 
previous tudy, we have compared the binding affinities of a 
variety of human influenza A and B virus strains for free 
~Neu5Ac and the simpliest natural receptor analogs Y-sialyl- 
lactose (Y-SL), 6'-sialyllactose (6'-SL), and 6'-sialyl-N-acetyl- 
lactosamine (6'-SLN) [13]. This comparison revealed clear dis- 
tinctions in the recognition of the asialic parts of these analogs 
by influenza viruses of different antigenic types and subtypes. 
In particular, subtype H 1 influenza A viruses were distinctive 
from H3 and type B strains in their much better binding of 
6'-SLN compared to 6'-SL, illuminating a possibility that the 
active sialo-sugar determinants for influenza viruses may be 
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Abbreviations." HA, hemagglutinin; Neu5Ac, 5-N-acetylneuraminic 
acid; RBS, virus receptor binding site; TLC, thin-layer chromatogra- 
phy; abbreviations for the sialyloligosaccharides ar  given in Table 1. 
extended above the terminal Neu5Ac-Gal moiety of a sialylol- 
igosaccharide. 
In the present study, to check this possibility in more detail 
and to further characterize specific sialo-sugar determinants 
recognized by human influenza virus subtypes in different con- 
texts, several linear and branched ~2-3- and a2 6-sialyloligo- 
saccharides were tested for their binding by H 1, H3 and type 
B influenza viruses. 
2. Experimental 
2.1. Sialic acid and sialosides 
Structural formulas and abbreviations of the sialosides used are 
shown in Table 1. 
Free Neu5Ac was purchased from Serva, Germany. Methyl- and 
benzyl a-glycosides of Neu5Ac were obtained from Syntesome, Ger- 
many. 3-Aminopropyl glycosides ofsialyl-Lewis and sialyl-Lewis were 
prepared as described in [14]. Y-SL, 6'-SL, LSTa, LSTb, LSTc, 
MSLNH, and DSLNT from human milk and Y-SLN, 6'-SLN, and 
DSGGn from human urine were isolated by subsequent ion-exchange 
chromatography onDowex 1 x 2 [15], ion-pair reverse-phase HPLC 
[16], and normal phase HPLC [17]. Structure and purity of all com- 
pounds were estimated by ~H NMR (500 MHz) spectroscopy [16,18], 
2.2. Viruses 
Seed stocks of influenza viruses A/USSR/90/77 (H1N1), and B/ 
USSR/100/83 were obtained from the Collection of viruses of the D.I. 
Ivanovsky Institute of Virology, Moscow. A/USSR/3/85 strain (H3N2) 
was kindly provided by Dr. M.A. Yakhno (D.I. Ivanovsky Institute of 
Virology). Viruses were grown in 10-day-old embryonated chicken eggs 
and were used without further purification. 
2.3. Binding assay 
The binding of the free Neu5Ac and sialosides to the RBSs of the 
viruses was evaluated by the ability of the ligand to compete with the 
binding to the solid-phase immobilized virus of the standard peroxi- 
dase-labeled fetuin preparation. The assay was performed, and the 
binding affinity constants (Kd) were calculated essentially as described 
previously [13,19]. To improve the reliability of results, replicate assays 
were done on different days, and the data were averaged. Twofold or 
higher differences in the values of binding affinity constants presented 
in the Table 1 are statistically significant. 
3. Results and discussion 
In this study, three strains of the currenlty circulating in 
humans influenza virus types and subtypes (type A, subtype H 1 
and H3; type B) were tested for their binding of free Neu5Ac 
and a number of sialyloligosaccharides structurally identical to 
the terminal sequences found in natural sialylglycoproteins and 
gangliosides, The strains were chosen from the previously stud- 
ied large virus panels taking into account heir good represen- 
tation of the most typical receptor-binding characterisitics of 
corresponding virus type and subtype [13]. 
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The binding affinity constants for the complexes of the vi- 
ruses with Neu5Ac and sialosides determined in a competitive 
ligand binding assay [19] are presented in the Table 1. 
Free N-acetylneuraminic acid in solution is a mixture of ~- 
and fl-anomers. Only the former is presented in natural oligo- 
saccharide sequences, and the fl-anomer do not bind to influ- 
enza virus HA [10,20]. By comparing the virus affinity for the 
free ~Neu5Ac (assuming its 5% content in the mixture [10]) and 
for the sialosides, a contrubution of the asilic parts to the 
binding energy can be assessed. As can be seen from the Table 
1, this contribution varies depending on both the virus and on 
the sialoside. The main effects are summarized below. 
1. 3"-SL, 3"-SLN, SLe x, and LSTa. Type A viruses bind these 
Neu5Acc~2-3Gal-terminated monovalent oligosaccharides with 
the same affinity as free ~Neu5Ac, with the exclusion of H3 
revealing somewhat better binding of 3'-SLN compared to both 
Neu5Ac and 3'-SL. Thus, with this single exclusion, sialic acid 
moiety appears to be the only specific binding epitope recog- 
nized by H1 and H3 substype strains in these oligosaccharide 
sequences, and neither penultimate Gal, nor more distant sugar 
residues interact with the receptor-binding sites (RBSs) of the 
viruses. Since the effect of different recognition of 3'-SLN and 
3'-SL by A/USSR/3/85 is only slightly above the limits of the 
assay reproducibility, further testing of different H3 subtype 
strains would be needed to specify this finding. 
Type B virus does not bind free Neu5Ac, however, it binds 
four Neu5Acc~2-3Gal-terminated sialosides with equally high 
affinity. Thus, opposite to the case of the type A viruses, penul- 
timate Gal does participate in favorable specific interactions 
with the RBS of the type B strain. However, just like for the 
A strains, subsequent sugar rings are of lower, if any, impor- 
tance for the binding of the sialosides by type B HA. 
2. In marked contrast to both SLe x and LSTa, isomeric 
tetrasaccharide SLe a exhibits at least an order of magnitude 
lower affinity for the type A HAs. For the type B virus the 
difference is lower but significant. NMR analysis and molecular 
mechanics calculations on SLe × and SLe a performed in [21] 
suggested that these tetrasaccharides have very similar confor- 
mations except hat the GlcNAc residue in SLe a flips about 
180 ° compared to that in SLe ~. However, this particular steric 
orientation of GlcNAc in LSTa provides no measurable nega- 
tive effect on binding of the sialoside by the viruses, lowering 
the possibility of GlcNAc moiety being responsible for the poor 
binding of SLe a. Thus, presently we have no reasonable expla- 
nation for the different recognition of SLe ~ and SLe a determi- 
nants by influenza viruses. 
3. In the case of H3 and type B strains, the Galfll-4Glc- 
moiety of 6"-SL, 6"-SLN, and LSTc appears to participate in 
specific interactions with the viral hemagglutinin, the virus af- 
finity for these sialosides being at least 10-fold higher then for 
c~Neu5Ac. The binding is not affected substantially by substit- 
uents on the opposite sites of the Glc moiety, namely, by NAc 
at C-2 (6'-SLN) and by lactose at C-1 (LSTc). It seems, there- 
fore, that the Glc residue in the Neu5Acc~2-6Gal,81-4Glc-deter- 
minant is not in contact with the RBSs of H3 and type B viruses 
and the main contribution to the binding affinity of the sia- 
losides compared to free Neu5Ac is from penultimate Gal. For 
H3 viruses, this contribution can be provided, at least partially, 
by energetically favorable hydrophobic and Van der Waals 
interactions between the 6'-methylene group of Gal and Leu in 
position 226 of the H3 HA [13]. 
Opposite to the H3 and type B viruses, Galfll-4Glc part of 
6'-SL seems to interfere with the RBS of the subtype H1 virus 
(compare Kd for 6'-SL and for free Neu5Ac). This effect corre- 
lates with the poor recognition by H1 strains of the aglycons 
in the methyl- and benzyl sialosides, and reflects, in our opin- 
ion, unfavorable steric interactions with the RBS of the penul- 
timate to the glycosidic linkage methylene moieties of both 
synthetic and 2-6-1inked natural aglycons [13]. 
Despite poor binding of 6'-SL, H1 strain binds 6'-SLN and 
LSTc stronger than any other sialoside tested. The ability to 
differentiate between 6'-SL and 6'-SLN was found previously 
to be specific property of i l l  subtype human viruses [13]. How- 
ever, due to Glc moiety of 6'-SLN being in the reducing state, 
the biological relevance of this effect was somewhat unclear. 
Even better binding of LSTc observed in the present study 
strongly suggests that the RBS of H1 subtype viruses may be 
specifically adapted for the recognition of the Neu5Ac~2- 
6Galfll-4GlcNAc-terminated oligosaccharide chains which are 
often encountered in glycoproteins and gangliosides. 
4. MSLNH.  Although this sialoside carries the terminal sia- 
lyl-sugar sequence well recognized in other contexts by all three 
strains tested, it is not bound by any of them (compare MSLNH 
with 6'-SLN and LSTc). It seems probable, that the conforma- 
tional space available to the bulky and relatively flexible 1-6- 
1inked substituent at GIcNAc is severily restricted in the com- 
plex. 
5. In comparison with the three linear Neu5Ac~2-6Gal-ter- 
minated sialosides, LSTb is a poorer ligand for the viruses, 
especially for the type B one. Since epitopes recognized by the 
human viruses on 2 6-1inked sialosides are extended on the 
penultimate o Neu5Ac sugar ring (see above, item 3 and [13]), 
weaker binding of LSTb may result from (i) structural differ- 
ences between penultimate GIcNAc and Gal, (ii) additional Gal 
substituent at position 3' of GIcNAc, and (iii) lactose core. 
6. The binding data for disialosides DSLNT and DSGGn 
seem to allow rational interpretation i  terms of independent 
recognition by the viruses of each of two sialic acid containing 
epitopes with no significant interference between them. 
For example, the affinities for DSLNT of H1 and type B 
strains are close to these for LSTa. Thus, Neu5Acc~2-6GlcNAc 
determinant of DSLNT does not contribute to any marked 
extent o the binding of the disialosides by these two strains, 
in consistense with their poor recognition of LSTb. 
H3 strain should bind both sialyl-sugar determinants of 
DSLNT as being represented in LSTa and LSTb, respectively. 
Indeed, the affinity for DSLNT is higher compared to both 
LSTa and LSTb. 
DSGGn represents important terminal sialyloligosaccharide 
sequence encountered in O-linked oligosaccharides of 
glycoproteins and certain gangliosides. It is structurally close 
to the corresponding non-reducing part of DSLNT, and it is 
not unexpectable that the affinities of the viruses for two disia- 
losides are rather similar. Of note are statistically significant 
small difference in binding of the two sialosides by H3 strains. 
Unlike H1 and B strains, the former reveals the ability to bind 
the Neu5Ac~2-6-X-branches of DSLNT and DSGGn and may 
be more sensitive to the difference in X (GlcNAcfl l-3Galfl l -  
4Glc versus GalNAc). 
Basing on the results presented above the following most 
distinct features of recognition of sialyl-sugar determinants by 
human influenza viruses can be noted. 
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Table 1 
Influenza virus binding of Neu5Ac and sialosides (Kd, mM) 
59 
0ompound Virus 
A/USSR/90/77 A/USSR/3/85 B/UBSR/IOO/83 
(H1) (H3) (B) 
0~euSAo 0.4 
NeuSAo0~e 2.3 
NeuSAoo.Bn 1.3 
.Ne~A~ -3Gal.-t erminat ed monosialosides 
N..e....~...A.~-..3.G~..]:.I31-401o (3' -SL) O. 3 
Ne~...A~-..3G .a.l131-4GIoNAo (3' -SLN ) O. 3 
,.N...e.~A~-..3.q.~.llS1-401ot~Aop-0-R** (SLe x) 0.4 
I 
Yuoct1-3 
.N.e .~A~-3qalp1-301oNAop1-3Oalp1-401o 
~e45A~-3qalp1-30Zo~Aop-O-a** (ST,e a)
I 
Fuo~1-4 
1.3 >5* 
0.45 1.2 
0.07 1 
I .1 0.11 
0.5 0.0? 
1.3 0.13 
(I,STa) 0.3 1.3 
>5 >10 
_/ll_e_u~Ao~_ -_6_G_al (_GIc_IILAo_)-t ermlnat ed monoslalosides 
N__e_u~Ae~t2 -6eal[B4Glo (6'-SL) I .5 0.1 
N_e_u~Aoa2 -6Gal ~1-4GloNAo (6 '-SI/~) 0.1 O.15 
N__e_u~Aoa2-6Galp1-4GloNAo~1-3Gal~1-4Gio (l~To) O. 03 O. 15 
N_e__u~Ao(Ze-60al~1-401oNAop1-6 
! 
0ai01-3GIoNAop1-3Galp1-4(31o (~LNH) >5 >5 
Ne_~A___~2e_z6 
Gal~1-3_~lo_NA_opl-3Gal~1-4Glo (l~Tb) >2 O. 5 
Disialosides 
Ne~Aoa2 -6 
..N?~A~-.3qa.I~I-3_~I_o_NA_o_~S -3Qal ~1-401 o (DSLNT)0.15 0.1 
_N__e~l___og2_-6 
..Ne.u.SA.~-..3q..a...Z.~81-3~alNAo (DSQG.n) O. 15 O. 25 
O.17 
0 .7  
0.3 
0.3 
0.3 
>5 
>5 
O.15 
0.07 
*For compounds which were not inhibitory at the highest concentration tested, only lower limit of dissociation constant could be estimated• 
**R = CHzCH2CH2NH 2. 
• (i) In Neu5Ac~2-3Gal-terminated oligosaccharides Neu5Ac 
moiety is the only specific binding epitope recognized by influ- 
enza A strains. 
(ii) In Neu5Ac~2-6Gal-X-terminated s quences, specific 
binding epitope for H3 virus extends to the penultimate Gal, 
while that one for H1 strain includes Neu5Ac and the GIcNAc 
moiety of Neu5Ac~2-6Galfl 1-4GlcNAc. 
(iii) Type B virus binds Neu5Ac only in context of underlying 
galactose with the preference for the Neu5Ac~2-3Gal epitope 
over Neu5Ac~2-6Gal one. 
(iv) Penultimate to the mentioned above specific determi- 
nants, as well as more distant parts of sialyloligosaccharides 
either contribute less significantly to the binding affinity, or 
interfere with the binding of the specific determinant. 
These features are consistent with the data on the receptor- 
binding properties of influenza viruses obtained in previous 
studies on virus binding to desialylated/specifically resialylated 
erythrocytes [1,4,5] and glycoproteins [3]. In the first case, 
human influenza A virus strains of HI, H2, and H3 subtypes 
were found to be distinct from the avian strains of the same 
subtype by their better binding to Neu5Acc~2-6Gal~l- 
4GlcNAc-terminated sequences as compared to Neu5Acc~2- 
3Galfll-3GalNAc-terminated ones. Our results eem to explain 
this effect for H1 and H3 subtypes in more details• Namely, 
unlike for the asialic part of the latter sequence, HAs of both 
human virus subtypes provide for favorable interactions with 
the N-acetyllactoseaminic moiety of Neu5Acc~2-6Galfll- 
4GlcNAc. However, HI and H3 HAs recognize the different 
domains of the aglycon. It may be speculated that this differ- 
ence occured spontaneously at the early stage of adaptation of 
the animal HI and H3 HAs to the cell-surface receptors of the 
human host. 
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Our results are less consistent with the data on virus binding 
to gangliosides adsorbed on TLC-plates [8,9]. For example, in 
a recent study [22], various type B virus strains were reported 
to prefer Neu5Ac~2-6Gal determinants exposed on gangli- 
osides over Neu5Ac~2-3Gal ones, while opposite specificity 
was revealed for the binding of sialyloligosaccharides in olu- 
tion (this study and [13,19]). Possible reasons for this inconsis- 
tense might be different exposure of the sugar determinants in 
the two cases, steric accessibility of the sialo-sugar groups in 
gangliosides being affected by the proximity of the ceramide 
moieties and/or by specific presentation of the ganglioside on 
the surface of TLC-plate. 
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